MA39153A1 - New heterocyclic compounds - Google Patents

New heterocyclic compounds

Info

Publication number
MA39153A1
MA39153A1 MA39153A MA39153A MA39153A1 MA 39153 A1 MA39153 A1 MA 39153A1 MA 39153 A MA39153 A MA 39153A MA 39153 A MA39153 A MA 39153A MA 39153 A1 MA39153 A1 MA 39153A1
Authority
MA
Morocco
Prior art keywords
heterocyclic compounds
compounds
new heterocyclic
pharmaceutically acceptable
relates
Prior art date
Application number
MA39153A
Other languages
French (fr)
Inventor
Ranjit Desai
Rajesh Bahekar
Dipam Patel
Kiran Shah
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority claimed from PCT/IN2015/000063 external-priority patent/WO2015132799A2/en
Publication of MA39153A1 publication Critical patent/MA39153A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des composés hétérocycliques de formule générale (i), leurs sels pharmaceutiquement acceptables, solvates pharmaceutiquement acceptables, énantiomères, diastéréoisomères, et polymorphes. L'invention concerne également des procédés de préparation de ces composés, des compositions pharmaceutiques contenant ces composés, et leur utilisation en tant qu'inhibiteurs sélectifs de la tyrosine kinase de bruton (btk).(i)The present invention relates to heterocyclic compounds of general formula (i), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereoisomers, and polymorphs. The invention also relates to processes for the preparation of these compounds, pharmaceutical compositions containing these compounds, and their use as selective inhibitors of broncine tyrosine kinase (btk).

MA39153A 2014-07-11 2015-02-02 New heterocyclic compounds MA39153A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2271MU2014 2014-07-11
PCT/IN2015/000063 WO2015132799A2 (en) 2014-02-03 2015-02-02 Novel heterocyclic compounds

Publications (1)

Publication Number Publication Date
MA39153A1 true MA39153A1 (en) 2018-03-30

Family

ID=62203552

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39153A MA39153A1 (en) 2014-07-11 2015-02-02 New heterocyclic compounds

Country Status (1)

Country Link
MA (1) MA39153A1 (en)

Similar Documents

Publication Publication Date Title
PH12016501440A1 (en) Novel heterocyclic compounds
MA42230B1 (en) Bicyclic derivatives, process for their preparation, and pharmaceutical compositions containing them
MA37405A1 (en) Heterocyclyl compounds
EA201650031A1 (en) DERIVATIVES PYRROLIDIN-2,5-DIONA, PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION AS IDO1 INHIBITORS
MA40225A (en) SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS
EA201691428A1 (en) BICYCLIC HETEROCYCLIC DERIVATIVES AS IRAK4 INHIBITORS
MA45222A (en) NEW PIPERIDINYL DERIVATIVES, PROCESS FOR THE PREPARATION OF THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201890086A1 (en) 1,4-substituted derivatives of piperidine
MA42231B1 (en) New hydroxy acid derivatives, process for their preparation, and pharmaceutical compositions containing them
MA40123A1 (en) Pyrimidines used as factor xia inhibitors
TN2016000188A1 (en) 2,6-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS
EA201691803A1 (en) HUMAN PLASMA KALLIKREIN INHIBITORS
MA38138A1 (en) New derivatives of quinolone
MX2016016516A (en) Phosphatidylinositol 3-kinase inhibitors.
MA38175A1 (en) Lactams fused to an aryl and heteroaryl
EA202090052A1 (en) IMIDAZOLE-CONTAINING ALK2 KINASE INHIBITORS
MX2016016530A (en) Phosphatidylinositol 3-kinase inhibitors.
MA38287A1 (en) New aminopyrazine derivatives for the treatment or prevention of cancer
EA201390717A1 (en) 3- (AMINOARIL) PYRIDINE CONNECTIONS
EA201492170A1 (en) NEW CYPRIDE N-PYRIDINYLAMIDES SUBSTITUTED AS A KINAZ INHIBITOR
PE20170946A1 (en) 2-AMINO-6- (DIFLUOROMETIL) - 5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINES AS BACE1 INHIBITORS
EA201692557A1 (en) CINOLYSINUM DERIVATIVES AS PI3K INHIBITORS
JOP20190233A1 (en) Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase
MA40366A (en) TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMA INHIBITORS
TR201819805T4 (en) FLAVAGLIN DERIVATIVES.